このページの翻訳は実験的なもので、現在開発中です。お待ちしております!
United Laboratories International Holdings 将来の成長
Future 基準チェック /06
United Laboratories International Holdings利益と収益がそれぞれ年間1.7%と5.5%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に18.2% 1.6%なると予測されています。
主要情報
1.7%
収益成長率
1.6%
EPS成長率
Pharmaceuticals 収益成長 | 10.6% |
収益成長率 | 5.5% |
将来の株主資本利益率 | 18.2% |
アナリストカバレッジ | Good |
最終更新日 | 30 May 2024 |
今後の成長に関する最新情報
Recent updates
Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified
Feb 29The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement
Jan 04United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt
Dec 14With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case
Nov 26Is United Laboratories International Holdings (HKG:3933) A Risky Investment?
Aug 31Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?
Aug 10United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet
Dec 23Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?
Oct 19Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?
Aug 30Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?
Mar 08The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It
Feb 18The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 03Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?
Jan 19We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide
Jan 04These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Dec 20What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?
Dec 07The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?
Nov 23業績と収益の成長予測
日付 | 収益 | 収益 | フリー・キャッシュフロー | 営業活動によるキャッシュ | 平均アナリスト数 |
---|---|---|---|---|---|
12/31/2026 | 16,251 | 2,862 | N/A | 3,556 | 6 |
12/31/2025 | 15,566 | 2,753 | N/A | 3,414 | 7 |
12/31/2024 | 14,858 | 2,761 | N/A | 3,054 | 7 |
12/31/2023 | 13,740 | 2,701 | 1,114 | 2,439 | N/A |
9/30/2023 | 13,399 | 2,469 | 1,376 | 2,504 | N/A |
6/30/2023 | 13,059 | 2,236 | 1,637 | 2,568 | N/A |
3/31/2023 | 12,197 | 1,909 | 1,444 | 2,300 | N/A |
12/31/2022 | 11,334 | 1,581 | 1,251 | 2,031 | N/A |
9/30/2022 | 10,750 | 1,288 | 1,066 | 1,683 | N/A |
6/30/2022 | 10,166 | 995 | 882 | 1,336 | N/A |
3/31/2022 | 9,935 | 991 | 968 | 1,439 | N/A |
12/31/2021 | 9,703 | 988 | 1,055 | 1,543 | N/A |
9/30/2021 | 9,445 | 1,056 | 1,047 | 1,647 | N/A |
6/30/2021 | 9,187 | 1,123 | 1,039 | 1,752 | N/A |
3/31/2021 | 8,980 | 913 | 1,035 | 1,660 | N/A |
12/31/2020 | 8,772 | 703 | 1,030 | 1,568 | N/A |
9/30/2020 | 8,690 | 626 | 1,128 | 1,625 | N/A |
6/30/2020 | 8,607 | 549 | 1,226 | 1,683 | N/A |
3/31/2020 | 8,500 | 595 | 1,293 | 1,742 | N/A |
12/31/2019 | 8,393 | 642 | 1,361 | 1,801 | N/A |
9/30/2019 | 8,100 | 765 | 1,147 | 1,618 | N/A |
6/30/2019 | 7,808 | 888 | 932 | 1,436 | N/A |
3/31/2019 | 7,659 | 785 | 806 | 1,324 | N/A |
12/31/2018 | 7,511 | 683 | 681 | 1,213 | N/A |
9/30/2018 | 7,395 | 373 | 640 | 1,104 | N/A |
6/30/2018 | 7,280 | 64 | 599 | 995 | N/A |
3/31/2018 | 7,053 | 73 | 447 | 883 | N/A |
12/31/2017 | 6,827 | 82 | 296 | 770 | N/A |
9/30/2017 | 6,640 | -34 | N/A | 957 | N/A |
6/30/2017 | 6,454 | -150 | N/A | 1,144 | N/A |
3/31/2017 | 6,266 | -211 | N/A | 1,109 | N/A |
12/31/2016 | 6,078 | -272 | N/A | 1,074 | N/A |
9/30/2016 | 6,083 | -216 | N/A | 976 | N/A |
6/30/2016 | 6,076 | -159 | N/A | 875 | N/A |
3/31/2016 | 6,195 | -32 | N/A | 1,182 | N/A |
12/31/2015 | 6,446 | 92 | N/A | 1,516 | N/A |
9/30/2015 | 6,597 | 148 | N/A | 1,522 | N/A |
6/30/2015 | 6,711 | 201 | N/A | 1,521 | N/A |
3/31/2015 | 6,565 | 373 | N/A | 1,460 | N/A |
12/31/2014 | 6,422 | 545 | N/A | 1,400 | N/A |
9/30/2014 | 6,179 | 552 | N/A | 1,436 | N/A |
6/30/2014 | 6,101 | 574 | N/A | 1,511 | N/A |
3/31/2014 | 6,112 | 306 | N/A | 1,347 | N/A |
12/31/2013 | 5,972 | 38 | N/A | 1,155 | N/A |
9/30/2013 | 5,829 | 33 | N/A | 924 | N/A |
6/30/2013 | 5,639 | 28 | N/A | 682 | N/A |
アナリストによる今後の成長予測
収入対貯蓄率: 3933の予測収益成長率 (年間1.7% ) は 貯蓄率 ( 2.2% ) を下回っています。
収益対市場: 3933の収益 ( 1.7% ) Hong Kong市場 ( 11.8% ) よりも低い成長が予測されています。
高成長収益: 3933の収益は増加すると予測されていますが、大幅には増加しません。
収益対市場: 3933の収益 ( 5.5% ) Hong Kong市場 ( 7.9% ) よりも低い成長が予測されています。
高い収益成長: 3933の収益 ( 5.5% ) 20%よりも低い成長が予測されています。
一株当たり利益成長率予想
将来の株主資本利益率
将来のROE: 3933の 自己資本利益率 は、3年後には低くなると予測されています ( 18.2 %)。